V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20196981 | 20152612 | 1.6 | 64 | null | 2020-10-26 | 2020-10-27 | Docetaxel | null | null | DOCETAXEL | 101321677 |
| 20196991 | 20152613 | 1.72 | 51.6 | null | 2019-06-25 | 2019-06-25 | Cetuximab + FOLFIRI cycle1 | 02 | null | DOCETAXEL | 100810515 |
| 20196994 | 20152614 | 1.67 | 65.7 | Curative (C) | 2017-03-11 | 2017-04-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101158263 |
| 20196998 | 20152615 | null | 55.2 | Palliative (P) | 2017-07-22 | 2017-07-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100899020 |
| 20196999 | 20152616 | 1.66 | 62 | null | 2019-02-15 | 2019-02-17 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100466039 |
| 20197002 | 20152617 | 1.63 | 49.8 | null | 2016-12-27 | 2016-12-28 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100771478 |
| 20197003 | 20152618 | 1.66 | 61.8 | Palliative (P) | 2017-01-02 | 2018-08-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101280654 |
| 20197006 | 20152619 | 1.66 | 78 | null | 2014-06-20 | 2016-07-21 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101361866 |
| 20197009 | 20152620 | 1.81 | 94 | Palliative (P) | 2021-02-08 | 2021-03-13 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101382570 |
| 20197011 | 20152621 | 1.63 | 74 | Palliative (P) | 2016-07-02 | 2016-07-07 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101835877 |
| 20197017 | 20152622 | 1.74 | 62.85 | null | null | 2017-03-19 | Docetaxel | 02 | null | DOCETAXEL | 100380943 |
| 20197023 | 20152623 | 1.71 | 54.4 | null | 2021-10-21 | 2021-11-04 | Docetaxel | 02 | null | DOCETAXEL | 100129886 |
| 20197031 | 20152624 | 1.74 | 67.4 | Palliative (P) | 2019-03-07 | 2019-03-07 | Gemcitabine + Capecitabine | null | null | CAPECITABINE + GEMCITABINE | 101337046 |
| 20197039 | 20152625 | 1.69 | 86.9 | Palliative (P) | 2017-01-06 | 2017-01-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100816246 |
| 20197046 | 20152626 | 1.74 | 79.2 | Palliative (P) | 2018-01-22 | 2018-08-05 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100188428 |
| 20197053 | 20152627 | 1.94 | 64.1 | null | 2019-05-06 | 2019-05-29 | Docetaxel | null | null | DOCETAXEL | 101167388 |
| 20197058 | 20152628 | 1.86 | 76.3 | Palliative (P) | null | 2018-03-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100291601 |
| 20197066 | 20152629 | 1.84 | 51.6 | Palliative (P) | 2018-02-14 | 2018-02-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100822350 |
| 20197076 | 20152630 | 1.69 | 44.1 | null | 2018-07-08 | 2018-07-28 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100667551 |
| 20197077 | 20152631 | 1.69 | 81.45 | Palliative (P) | 2019-12-04 | 2019-12-06 | Docetaxel | 02 | N | DOCETAXEL | 100931842 |
| 20197078 | 20152632 | 1.7 | 55 | Neo-adjuvant (N) | 2018-08-04 | 2018-11-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101178434 |
| 20197085 | 20152633 | 1.84 | 54.4 | Adjuvant (A) | 2016-04-22 | 2016-05-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100110659 |
| 20197095 | 20152634 | 1.83 | 74.8 | Palliative (P) | 2021-04-28 | 2021-09-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100181218 |
| 20197106 | 20152635 | 1.69 | 123 | Palliative (P) | 2018-05-17 | 2018-05-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100902132 |
| 20197108 | 20152636 | 1.68 | 67 | Palliative (P) | 2020-01-07 | 2020-01-21 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100266923 |
| 20197111 | 20152637 | 1.66 | 71 | null | 2016-11-24 | 2016-12-12 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101200549 |
| 20197114 | 20152638 | 1.59 | 98 | Adjuvant (A) | 2018-04-10 | 2018-10-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101764216 |
| 20197115 | 20152639 | 1.95 | 52.3 | Palliative (P) | 2019-12-26 | 2020-04-05 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100733025 |
| 20197119 | 20152640 | 1.48 | 46.5 | null | 2019-11-18 | 2019-11-24 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100002395 |
| 20197122 | 20152641 | 1.63 | 83 | null | 2020-11-22 | 2020-11-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100991785 |
| 20197126 | 20152642 | 1.84 | 57.4 | Palliative (P) | 2021-01-04 | 2021-01-04 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100703102 |
| 20197128 | 20152643 | 1.72 | 80.7 | Palliative (P) | 2018-04-04 | 2018-09-17 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100192397 |
| 20197130 | 20152644 | 1.75 | 73 | null | 2016-11-08 | 2017-02-20 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101184869 |
| 20197133 | 20152645 | 1.69 | 43.3 | Palliative (P) | 2016-08-30 | 2016-09-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101776763 |
| 20197135 | 20152646 | 1.68 | 98.1 | null | 2017-09-02 | 2017-09-12 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101600977 |
| 20197138 | 20152647 | 1.72 | 64.5 | Palliative (P) | 2016-03-15 | 2016-03-17 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100098414 |
| 20197139 | 20152648 | 1.83 | 64.6 | Palliative (P) | 2019-04-05 | 2019-05-07 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101045041 |
| 20197140 | 20152649 | 1.62 | 78 | Palliative (P) | 2017-04-03 | 2017-04-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100488821 |
| 20197141 | 20152650 | 1.66 | 64.4 | Palliative (P) | 2019-02-15 | 2019-07-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101667895 |
| 20197142 | 20152651 | 1.88 | 58 | Palliative (P) | 2017-09-20 | 2017-10-22 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100951212 |
| 20197143 | 20152652 | 1.84 | 71.6 | Palliative (P) | 2016-03-14 | 2016-03-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100403802 |
| 20197146 | 20152653 | 1.52 | 103 | Palliative (P) | 2016-07-18 | 2016-09-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100516794 |
| 20197152 | 20152654 | 1.67 | 78 | Palliative (P) | 2016-10-31 | 2017-06-27 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101057879 |
| 20197153 | 20152655 | 1.61 | 68.8 | Palliative (P) | 2017-02-18 | 2017-02-18 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101346124 |
| 20197159 | 20152656 | 1.59 | 50.5 | Palliative (P) | 2016-12-27 | 2017-03-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100116477 |
| 20197165 | 20152657 | 1.63 | 48.7 | Palliative (P) | 2022-04-17 | 2022-05-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101788470 |
| 20197171 | 20152658 | 1.59 | 48 | Palliative (P) | 2019-06-30 | 2019-10-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100380772 |
| 20197175 | 20152659 | 1.63 | 55.9 | Palliative (P) | 2021-06-08 | 2021-07-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100181994 |
| 20197180 | 20152660 | 1.81 | 53 | Palliative (P) | 2019-10-08 | 2019-10-08 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101550203 |
| 20197182 | 20152661 | 1.77 | 84.5 | Neo-adjuvant (N) | 2020-02-15 | 2020-02-15 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | CAPECITABINE + GEMCITABINE | 100846591 |